Jennifer Marcello

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Journal of Clinical Oncology · 2007 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

Amy P. Abernethy, Christine F. McDonald, Peter Frith et al. · The Lancet · 2010 · 485 citations

Medicine, Internal Medicine, Respiratory Therapy +14

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Sith Sathornsumetee, Yiting Cao, Jennifer Marcello et al. · Journal of Clinical Oncology · 2008 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh et al. · Neuro-Oncology · 2010 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

David A. Reardon, Annick Desjardins, James J. Vredenburgh et al. · Journal of Neuro-Oncology · 2009 · 229 citations

Medicine, Oncology, Pharmacology +14